Blood & Cancer-logo

Blood & Cancer

Health & Wellness Podcasts >

Interview-style hematology/oncology podcast from MDedge Hematology-Oncology. The show is hosted by Dr. David Henry with Pearls from Dr. Ilana Yurkiewicz for clinical hematology and oncology health care professionals. The information in this podcast is provided for informational and educational purposes only.

Interview-style hematology/oncology podcast from MDedge Hematology-Oncology. The show is hosted by Dr. David Henry with Pearls from Dr. Ilana Yurkiewicz for clinical hematology and oncology health care professionals. The information in this podcast is provided for informational and educational purposes only.
More Information

Location:

United States

Description:

Interview-style hematology/oncology podcast from MDedge Hematology-Oncology. The show is hosted by Dr. David Henry with Pearls from Dr. Ilana Yurkiewicz for clinical hematology and oncology health care professionals. The information in this podcast is provided for informational and educational purposes only.

Language:

English

Contact:

2402212400


Episodes

Lung cancer: PD, PDL-1, and immunotherapy

5/16/2019
More
Howard “Skip” Burris, MD, the chief medical officer of Sarah Cannon Cancer Institute in Nashville, Tenn., joins the podcast as the guest host for a discussion of PD1 and PDL1 in the treatment of lung cancer. Dr. Burris interviews Melissa Johnson, MD, the associate director of lung cancer research at Sarah Cannon. Plus, in Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University dives into the financial realities of cancer care. Show notes By Emily Bryer, DO, resident...

Duration:00:36:10

ITP: When and how, pregnant patients

5/9/2019
More
Episode 15 Host David Henry, MD, welcomes David J. Kuter, MD, of Harvard and Massachusetts General Hospital to talk about idiopathic thrombocytopenic purpura. He answers questions like: what are the causes? When do you treat? In Clinical Correlation this week, Ilana Yurkiewicz, MD, explores pregnant patients. Show notes By Hitomi Hosoya, MD, PhD, resident in the department of internal medicine, Pennsylvania Hospital of the University of Pennsylvania Health System,...

Duration:00:32:18

CAR T-cell therapy: Development to access

5/2/2019
More
Howard “Skip” Burris, MD, the chief medical officer at Sarah Cannon Cancer Institute in Nashville, Tenn., joins the podcast as a guest host for a discussion on chimeric antigen receptor (CAR) T-cell therapy with Helen Heslop, MD, of Baylor College of Medicine, Houston. Dr. Heslop, who has been a leader in CAR T-cell therapy research, recently received a Lifetime Achievement Award from the American Society for Blood and Marrow Transplantation. Contact the show: podcasts@mdedge.com or...

Duration:00:33:23

ASCO GI 2019

4/25/2019
More
Daniel G. Haller, MD, of the University of Pennsylvania, Philadelphia, joins Blood & Cancer host David H. Henry, MD, also of the University of Pennsylvania, to review the top research presented at ASCO GI 2019. Plus, in Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University shares the story of a patient who had no questions about the details of his treatment but needed answers about the “big picture.” Show Notes By Emily Bryer, DO, resident in the department of...

Duration:00:22:21

Drug development stats and research

4/18/2019
More
Statistics 101 for the oncologist Episode 12: David L. Streiner, PhD, of McMaster University and the University of Toronto, joins Blood & Cancer host David Henry, MD, of Pennsylvania Hospital, Philadelphia, to break down the basic statistics knowledge that doctors need – but may not have – to understand and contextualize research findings. In Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University talks about reclaiming the term “sorry.” Dr. Yurkiewicz writes a...

Duration:00:27:07

Anemia in cancer

4/11/2019
More
You can contact Blood & Cancer at podcasts@mdedge.com and you can follow MDedge Hematology Oncology on Twitter @MDedgeHemOnc. Episode 11: Blood & Cancer host David Henry, MD, welcomes John Glaspy, MD, to talk about anemia in cancer. And in today's Clinical Correlation, Ilana Yurkiewicz, MD, talks apathy. Dr. Yurkiewicz has a column at MDedge, which you can find by clicking here. Show notes By Emily Bryer, DO, resident in the department of internal medicine, University of...

Duration:00:28:16

Breast Cancer, CDK4/6 Inhibitors

4/4/2019
More
We'd love to hear from you with ideas, suggestions, feedback, and questions for Dr. Henry or Dr. Yurkeiwicz at podcasts@mdedge.com and you can follow MDedge Hematology/Oncology at @MDedgeHemOnc. Blood & Cancer episode 10: CDK4/6 inhibitors in breast cancer Richard Finn, MD, of the Geffen School of Medicine at UCLA joins guest host Jame Abraham, MD, of the Cleveland Clinic to discuss CDK4/6 inhibitors in the treatment of breast cancer, from the first pivotal studies to efficacy and...

Duration:00:30:50

Sickle Cell Treatment, Part II

3/28/2019
More
The MDedge Daily news is a daily news briefing with the top four stories in clinical medicine news. It's available weekdays at 4:00 a.m. est where ever podcasts are found. Click here to learn more. Blood & Cancer Episode 09: John J. Strouse, MD, PhD, and Julie Kanter, MD, join guest host Ify Osunkwo, MD, of Levine Cancer Institute/Atrium Health in Charlotte, N.C., take a look at some of the thornier issues in sickle cell disease treatment, from caring for young adults to prescribing...

Duration:00:18:50

Sickle Cell Treatment, Part I:

3/21/2019
More
Episode 8: John J. Strouse, MD, PhD, and Julie Kanter, MD, join guest host Ify Osunkwo, MD, of Levine Cancer Institute/Atrium Health in Charlotte, N.C., to discuss current therapies for sickle cell disease, as well as new treatments and cures under development. Clinical Correlations: Ilana Yurkiewicz, MD, tackles informed consent and the capacity to choose in cancer care with a focus on the research setting. Dr. Yurkiewicz is a fellow in hematology and oncology at Stanford University...

Duration:00:26:26

Lymphoma in patients w/ HIV

3/14/2019
More
Stefan K. Barta, MD, of the University of Pennsylvania, joins David Henry, MD, to discuss the treatment and diagnosis of lymphoma in patients with HIV. In this week's Clinical Correlation, Ilana Yurkiewicz, MD, has Part 2 of her discussion on informed consent in cancer. Dr. Yurkiewicz is a fellow in hematology and oncology at Stanford University and is also a columnist for Hematology News. More from Dr. Yurkiewicz here. Notes, Transcripts, Links Show notes By Emily Bryer, DO Resident in...

Duration:00:25:18

Anticoagulation in cancer

3/7/2019
More
We'd love to hear from you with your ideas, suggestions for topics/guests, shoutouts to colleagues or mentors, questions for Dr. Henry or Dr. Yurkiewizc. To get in touch, please email us at podcasts@mdedge.com or follow us on Twitter @MDedgeHemOnc. In this episode, Alok Khorana, MD, of the Cleveland Clinic joins David H. Henry, MD, to discuss results from the CASSINI trial and what it means for anticoagulation in cancer patients. And Ilana Yurkiewicz, MD, begins part 1 of her look at...

Duration:00:31:29

KATHERINE trial and breast cancer

2/28/2019
More
Charles E. Geyer, MD, of Virginia Commonweath University joins guest host Jame Abraham, MD, of the Cleveland Clinic to discuss the KATHERINE trial and its impact on the treatment of HER2-positive breast cancer. And Ilana Yurkiewicz, MD, talks about whether it's better for physicians to be vague about prognosis. Show notes By Hitomi Hosoya, MD, PhD Resident in the department of internal medicine, University of Pennsylvania Health System The idea behind the KATHERINE trial was to...

Duration:00:25:38

How to read and review scientific papers

2/21/2019
More
Daniel G. Haller, MD, of the University of Pennsylvania joins David H. Henry, MD, to talk about the best ways to read and review the scientific literature. And Ilana Rachel Yurkiewicz, MD, talks about chaos and opportunity. Show notes By Hitomi Hosoya, MD, PhD, Resident in the department of internal medicine, University of Pennsylvania Health System - If you are a peer reviewer of a manuscript submitted to a journal, you should be unbiased, consistent, constructive, and focused on the...

Duration:00:21:24

ESMO 2018 and more

2/14/2019
More
David Henry, MD, welcomes Daniel G. Haller, MD, to rehash research from ESMO 2018 as well as the way the meeting itself was run. And Ilana Yurkiewicz, MD, stops by for this week’s Clinical Correlation. Dr. Yurkiewicz is a Hematology Fellow at Stanford and is also a columnist at MDedge Hematology/Oncology. More from Dr. Yurkiewicz here. Contact us: podcasts@mdedge.com MDedge on Twitter: @mdedgehemonc Dr. Ilana Yurkiewicz on Twitter: @ilanayurkiewicz SHOW NOTES By Emily Bryer,...

Duration:00:24:34

Biosimilars: Gary Lyman

2/7/2019
More
In this episode, Gary H. Lyman, MD (https://bitly.is/2UJzUly) joins David Henry, MD, (http://bit.ly/2MFDfzm) to talk about biosimilars. Dr. Lyman talks about the definition of biosimilars, how they are made, which are approved, and which ones are on the market. He also talks about extrapolation and interchangeability as well as where some biosimilars stand in both ASCO and NCCN guidelines for patients who are going into supportive care. And Ilana Yurkiewicz, MD...

Duration:00:30:40

Antiemetics: Richard Gralla

1/31/2019
More
In the first episode of Blood & Cancer, David Henry, MD (http://bit.ly/2MFDfzm), welcomes Richard J. Gralla, MD (http://bit.ly/2ShsxEv), or the Albert Einstein College of Medicine in New York. The topic today centers around antiemetics and ways to use them. And later, Ilana Yurkiewicz, MD (https://stanford.io/2RXPixR), debuts her segment Clinical Correlations all about hematology care. Visit MDedge/hematology-oncology Show Notes By Emily Bryer, DO References: Ann Oncol. 2014...

Duration:00:27:51

The JCSO Interview: Dr. Maura Sammon

8/7/2018
More
When cancer patients present to the emergency department with symptoms and say they’re being treated for cancer, it’s crucial for the attending physician to ascertain at the outset if the treatment is with chemotherapy or immunotherapy so that the appropriate symptom treatment can be initiated as early as possible. The key here is communication: first, between the oncologist and patient, so that the patient is aware of these nuances in advance of an emergency, and second, between the ED...

Duration:00:17:47

David Henry’s JCSO podcast, May - June 2018

8/3/2018
More
In his bimonthly podcast, Dr Henry, the JCSO Editor-in-Chief, discusses a round-up by JCSO Editor Dr Howard Burris of the top takeaways from this year’s annual ASCO meeting, as well as a series of articles focusing on CAR T-cell therapies. He also looks at reports on psychosocial factors and treatment satisfaction after radical prostatectomy; the impact of inpatient rehabilitation on outcomes for patients with cancer; the long-term effects of posttreatment exercise on pain in young women...

Duration:00:14:58

David Henry’s JCSO podcast, March - April 2018

8/1/2018
More
In his bimonthly podcast, Dr Henry, the JCSO Editor-in-Chief, discusses a round-up by JCSO Editor Dr Howard Burris of the top takeaways from this year’s annual ASCO meeting, as well as a series of articles focusing on CAR T-cell therapies. He also looks at reports on psychosocial factors and treatment satisfaction after radical prostatectomy; the impact of inpatient rehabilitation on outcomes for patients with cancer; the long-term effects of posttreatment exercise on pain in young women...

Duration:00:12:26

JCSO Interview with Dr Daniel Haller

3/29/2018
More
In this interview, Dr David Henry, the Editor-in-Chief of The Journal of Community and Supportive Oncology, and Dr Daniel Haller of the Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine in Philadelphia, discuss recent breakthrough studies in gastrointestinal cancers.

Duration:00:26:14